Optimised Cardio-Renal Care for CKD and heart disease
Official title: Optimised Multidisciplinary Cardiovascular and Renal Protection in Patients With Chronic Kidney Disease and Cardiovascular Disease: Effects on Diastolic Function, Cardiovascular and Renal Outcomes
Run by Odense University Hospital · NCT07835828 · Data updated 2026-11-12
This study tests whether a specialised Cardio-Renal Clinic can improve heart and kidney health and quality of life for adults with chronic kidney disease and cardiovascular disease.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 500 (estimated) |
| Sponsor | Odense University Hospital Academic / other |
| Locations | 1 site (Svendborg) |
| Status | Recruiting |
| Started | October 1, 2026 |
| Main results expected | October 1, 2038 |
| Study ends | October 1, 2038 |
| Registry record updated | October 15, 2026 |
| Trial ID | NCT07835828 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with both chronic kidney disease and established cardiovascular disease who can provide informed consent and meet specific kidney function and proteinuria criteria.
✕Probably not a fit
Patients with HFpEF but no CKD progression, or those unlikely to benefit from multidisciplinary cardio-renal optimization, may see limited improvement.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This interventional study examines a multidisciplinary Cardio-Renal Clinic designed to care for patients with both chronic kidney disease and cardiovascular disease, including HFpEF. Participants undergo a structured, guideline-based treatment plan and comprehensive baseline assessments, followed by long-term follow-up to compare outcomes with usual care. Primary questions focus on improvements in heart and kidney function, quality of life, symptoms, and physical ability after one year, with longer-term effects on mortality and major cardiovascular or renal events assessed over five years. The study leverages existing evidence for SGLT2 inhibitors and mineralocorticoid receptor antagonists while addressing gaps in real-world guideline implementation. Eligible participants are adults with CKD and established cardiovascular disease, excluding those with HF with reduced ejection fraction, diabetes, dialysis, kidney transplant, or limited life expectancy.
Why it matters
Potential benefit: If successful, patients could experience better heart and kidney health, fewer symptoms, and improved overall well-being through a coordinated, guideline-based care approach.
How similar studies have gone: Previous pilots and related trials suggest structured cardio-renal care can improve process measures and outcomes, though results vary by setting and population.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years old * Capable of giving written informed consent * Established chronic kidney disease, and at least two measurements of: 1) eGFR \<45 and \>15 mL/min/1.73 m², and/or 2) UACR \>200 mg/g, or 3) eGFR \<60 mL/min/1.73 m² and UACR \>30 mg/g. * Established cardiovascular disease, including prior acute coronary syndrome, chronic coronary syndrome, objective evidence of myocardial ischaemia, non-coronary atherosclerotic cardiovascular diase (stroke or peripheral arterial disease), heart failure with preserved ejection fraction, atrial fibrillation and/or flutter, clinically significant valvular disease, or hypertension treated with three or more antihypertensive drugs. Exclusion Criteria: * Established heart failure with reduced ejection fraction. * Diabetes type I or II * Patients receiving chronic dialysis or having of kidney transplant. * Expected life expectancy \<5 years. * Inability to understand the study procedures, comply with study requirements, or presence of any condition that, in the opinion of the research staff, may interfere with the patient's ability to participate in or complete the study. * Participation in another clinical trial with an investigational product or device that could interfere with the primary and/or secondary endpoints of this study.
Where it's running
-
Cardiovascular Research Unit, Odense University Hospital Svendborg
Svendborg, Denmark Recruiting
Study contacts
- Principal investigator: Søren Auscher, MD, PhD, Associated Professor — Odense University Hospital
- Study coordinator: Eline Panadevo, MD
- Email: eline.panadevo@rsyd.dk
- Phone: +45 63 20 24 02
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Home-based cardiovascular health screening for people turning 50, 55, 60, 65, 70 or 75 in Uppsala
This trial tests whether giving people a home blood pressure monitor, a dried blood spot kit, and a questionnaire can find more cardiovascular risk factors than usual care.
-
How kidneys handle protein and salt in people with HFpEF and obesity
This study will test how kidneys process protein and salt after a high-protein, high-sodium meal in adults with obesity and heart failure with preserved ejection fraction compared with healthy and obese-only adults.
-
Home exercise program for patients with advanced chronic kidney disease
This study is testing whether a simple home exercise program can help people with advanced chronic kidney disease feel better and improve their overall health.
-
AI-driven wearable monitoring for chronic heart failure
This project will try an AI-driven wearable and mini‑invasive device to see if continuous home monitoring reduces hospital visits and improves health for adults with chronic heart failure.
-
Predicting heart disease in patients with chronic kidney disease in Poland
This study is trying to see if collecting health data from people with chronic kidney disease in Poland can help predict heart problems and other related issues over time.
-
Investigating nutritional and environmental factors in elderly health
This study is trying to find out how nutrition and the environment affect the health of older people living in Nanshan to help prevent diseases like high blood pressure and diabetes.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.